Rabeprazole and Nail disorder - a phase IV clinical study of FDA data

Summary:

Nail disorder is reported as a side effect among people who take Rabeprazole (rabeprazole sodium), especially for people who are female, 60+ old, also take Arimidex, and have Osteoporosis.

The phase IV clinical study analyzes which people have Nail disorder when taking Rabeprazole. It is created by eHealthMe based on reports of 31,196 people who have side effects when taking Rabeprazole from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Nail disorder?

Nail disorder (disease of nail) is found to be associated with 749 drugs and 1,089 conditions by eHealthMe. Check the latest studies of Nail disorder.

On Jul, 14, 2026

31,196 people reported to have side effects when taking Rabeprazole.
Among them, 24 people (0.08%) have Nail disorder.

Among these 24 people:

What is the gender of people who have Nail disorder when taking Rabeprazole? *

female: 63.16 %
male: 36.84 %

What is the age of people who have Nail disorder when taking Rabeprazole? *

What are other drugs people take besides Rabeprazole? *

Magnesium Oxide: 6 people, 25.00%
Morphine: 6 people, 25.00%
Arimidex: 6 people, 25.00%
Zolpidem Tartrate: 4 people, 16.67%
Clobetasol Propionate: 3 people, 12.50%
Celecoxib: 3 people, 12.50%
Oxaliplatin: 3 people, 12.50%
Erlotinib Hydrochloride: 3 people, 12.50%
Ketoprofen: 3 people, 12.50%
Ursodiol: 3 people, 12.50%

What are other side effects people have besides Nail disorder? *

Rashes (redness): 7 people, 29.17%
Lower Limb Fracture: 6 people, 25.00%
Fever: 6 people, 25.00%
Skin Exfoliation (removal of the oldest dead skin cells): 5 people, 20.83%
Dry Skin: 5 people, 20.83%
Subclavian Vein Thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein): 4 people, 16.67%
Overdose: 4 people, 16.67%
Infective Spondylitis (infective inflammation of a spinal joint; characterized by pain and stiffness): 3 people, 12.50%
Oedema Peripheral (superficial swelling): 3 people, 12.50%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 12.50%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 25.00%
Insomnia (sleeplessness): 5 people, 20.83%
High Blood Cholesterol: 4 people, 16.67%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 16.67%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 4 people, 16.67%
High Blood Pressure: 3 people, 12.50%
Hypokalemia (low potassium): 2 people, 8.33%
Migraine (headache): 2 people, 8.33%
Fatigue (feeling of tiredness): 2 people, 8.33%
Facial Pain: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and have Nail disorder?

- Check whether Nail disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rabeprazole:

Rabeprazole (31,689 reports)

Nail disorder treatments and more:

Nail disorder (9,795 reports)

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nail disorder:

Nail disorder (749 drugs)

Browse all the conditions that are associated with Nail disorder:

Nail disorder (1,089 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole) and Rabeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.